Barleben L.,# Schneegans A.,# Uyar B., Bruneau A., Vasileva G., Flohr F., Kabrani E., Vasilakis T., Hammann L., Gebert P., Dietrich C., Bochow-Fitzner B., Arnold A., Sai S., Gröne F., Sander M., Conrad T., Gerard A., Piseddu I., Anz D., Jochum C., Akalin A., Hammerich L., Klose C., Tacke F., Di Virgilio M., Kolesnichenko M.* Epithelial NF-κB shapes protective Treg cell responses to restrain intestinal inflammation. Nat Comms. IF: 18.1 (accepted).

Kolesnichenko M*. Rejuvenating the aging gut by targeting senescence. Nat Aging. 2026 Jan;6(1):32-33. doi: 10.1038/s43587-025-01045-3. PMID: 41482517. IF: 25.0

Barleben L, Simon M, Drees L, Flohr F, Jochum C, Di Virgilio M, Tacke F, Bröer S, Wolf J, Kolesnichenko M*. Deep learning, deeper relief: pipeline toward tailored analgesia for experimental animal models. Front Immunol. 2025 Dec 12;16:1639881. doi: 10.3389/fimmu.2025.1639881. PMID: 41459492; PMCID: PMC12741108. IF: 7.0

Jakob MO, Sterczyk N, Boulekou S, Forster PM, Barleben L, Alzain N, Jarick KJ, Pirzgalska RM, Raposo B, Hansson K, Nyström EEL, Gondrand A, González-Acera M, Leclère PS, Lapson MS, Poggenseier S, Deshpande D, Velleman L, Breiderhoff T, Brunkhorst MF, Schüle AM, Guerra GM, Durek P, Mashreghi MF, Kühl AA, Chu C, Schneider C, Weidinger C, Siegmund B, Nordmann TM, Voehringer D, Patankar JV, Becker C, Birchenough GMH, Veiga-Fernandes H, Ronchi F, Kolesnichenko M, Diefenbach A, Klose CSN. Enteric nervous system-derived VIP restrains differentiation of LGR5+ stem cells toward the secretory lineage impeding type 2 immune programs. Nat Immunol. 2025 Dec;26(12):2227-2243. doi: 10.1038/s41590-025-02325-1. IF: 26.5

Drude N, Nagel-Riedasch S, Rosshart SP, Diefenbach A; “Charité 3R Wildling Mouse Model in Health and Disease (C3R Wildling HeaD)” consortium; Jordan S. A facility for laboratory mice with a natural microbiome at Charité – Universitätsmedizin Berlin. Lab Anim (NY). 2024 Dec;53(12):351-354. doi: 10.1038/s41684-024-01474-4. IF: 5.9

Kolesnichenko M*, Scheidereit C. Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts. Signal Transduct Target Ther. 2024 Jul 29;9(1):179. doi: 10.1038/s41392-024-01893-2. IF: 40.8